April 25th 2024
Coverage from the Community Oncology Alliance Community Oncology Conference, held April 4-5, 2024, in Orlando, Florida.
April 23rd 2024
Treatment escalation plans can successfully be implemented into routine oncology practice, according to one study.
April 18th 2024
Integration of prostate MRI may improve the balance of patient harms and benefits in prostate cancer screening.
April 8th 2024
Accelerated biological aging may be behind why some types of cancer are on the rise in young adults, researchers find.
Trends in the 2012 Eisai Oncology Digest: Counseling and Communication of Cancer Treatment
Read More
Mark Zitter, MBA, Discusses Oncology Pathways
Mark Zitter, MBA, CEO of the Zitter Group, states that oncology pathways can standardize the way care is delivered while improving quality and reducing costs.
Sanofi, Regeneron Win U.S. Approval for Cancer Medicine
How Fake Cancer Drugs Entered U.S.
COA Oncology Medical Home Committee Approves 16 Measures To Evaluate And Reward Quality, Cost Efficiency And Outcomes
Automated Phone and Mail Population Outreach to Promote Colorectal Cancer Screening
Automated phone and mail population outreach resulted in an almost 4-fold increase in the rate of screening for colorectal cancer even without an office visit.
Payment Reform Models
Panelists talk about payment reform models, such as accountable care organizations and bundled payments, as a response to new treatments in oncology.
Drug Cost Control in Oncology
Panel members are asked to discuss what drives the cost of drugs in cancer care. They also discuss the role companion diagnostics and personalized medicine play in oncology.
Introduction and Overview of Results from CLEOPATRA Trial
AJMC's Co-Editor-in-Chief, Michael E. Chernew, PhD, Lee N. Newcomer, MD, MHA, UnitedHealthcare, and Sandra M. Swain, MD, Washington Cancer Institute, Medstar Washington Hospital Center.
ACO Rollout Continues With 89 New Networks
Quality of Life Better with Less Care at the End
Analysis: Drug Costs Become Bigger Issue in Cancer Care
Great Strides Made In Developing New Medicines For Cancer
Inefficiencies in Oncology Continue to Prove Costly
The Center for Health Value Innovation (CHVI) presented a webinar yesterday that touched on clinical pathways for oncology and how value-based approaches will help to improve health and financial outcomes.
ASCO: Cymbalta Tames Post-Chemo Pain
Cancer Treatments Grow More High-Tech: 'Smart Bomb' Drugs, Immune Boosters are Seeing Success
ASCO Advocates for New Payment Models That Reward Quality of Care
Insurers Forcing Patients to Pay More for Costly Specialty Drugs
Screening Finds Skin Cancer, But Does It Save Lives?
Value-Based Reimbursement in Oncology
Getting On Pathway?
The 2012 New York ASCO Checklist
Testing for ALK-Positive NSCLC
Signaling the Future of Personalized Medicine
Prostate Cancer
Long-Term Breast Cancer Patient Follow-Up Care
Money Well Spent?
Myeloproliferative Disorders and Myelofibrosis
BRCA1/2 Genetic Testing Found Cost-Effective in Current Era
SABCS Conference Coverage
Trends in the 2012 Eisai Oncology Digest: Patient Demographics and Cancer Treatment Goals
This article was sponsored by Eisai Inc. The 2012 Eisai Oncology Digest was commissioned and funded by Eisai Inc.
Literature Review
Multiple Myeloma: Pre-Transplant Induction, Consolidation, and Maintenance Therapy
On the Horizon for Multiple Myeloma
Availability of Newer Agents May Lower Healthcare Costs
Oncology Hit Hard by SGR Debacle
Interview With Allen S. Lichter, MD, Chief Executive Officer, American Society of Clinical Oncology